MSI2 and colorectal carcinoma: And CRC patients were classified into high and low expression groups based on MSI2 transcript levels, and we observed that the expression of GPX4, SLC7A11, FANCD2, NFE2L2 and HSPA5 was upregulated in CRC patients (Fig. 1E).